Literature DB >> 7065484

Effect of flunarizine on canine cerebral cortical blood flow and vascular resistance post cardiac arrest.

B C White, D S Gadzinski, P J Hoehner, C Krome, T Hoehner, J D White, J H Trombley.   

Abstract

Twelve dogs were anesthetized and instrumental for determination of CVP, arterial pressure, intracranial pressure, left atrial pressure, and frontal cerebral cortical blood flow (CCBF) by the thermal method. A catheter was introduced into the venous return of the cerebral confluence to allow determination of cerebral A-V oxygen saturation differences. The animals were placed on cardiac bypass using a circuit from the right atrium to the pulmonary artery and a second circuit from the left ventricular apex to the left femoral artery. A heat exchanger was used to maintain a constant blood temperature of 37 C in the output of the left side bypass circuit. All animals were heparinized during bypass. Ventricular fibrillation was induced after completion of the bypass surgery. Two dogs served as controls. Pre-arrest determinations of hemoglobin, glucose, CCBF, and cerebral A-V oxygen differences were taken. Full circulatory arrest was carried out for 20 minutes by shutting off the cardiac bypass. Resuscitation was achieved by resumption of bypass perfusion. Acid-base balance was corrected quickly, and pre-arrest perfusion pressure was achieved and maintained for 90 minutes. All pressure parameters were monitored continuously. All pre-arrest determinations were repeated at 20, 40, 60, and 90 minutes post resuscitation. Five dogs were treated with 6 microgram/kg flunarizine administered IV drip over 10 minutes immediately post reperfusion. Five dogs were not treated post arrest. Treated animals had a prompt return of CCBF rates equal to or greater than pre-arrest flow, which persisted throughout the period of post-arrest observation. Untreated animals had markedly reduced CCBF and increased resistance. CCBF uniformly proceeded to near zero flow by 90 minutes. The ICP was not significantly altered by treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065484     DOI: 10.1016/s0196-0644(82)80235-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  7 in total

Review 1.  The physiology of cardiopulmonary resuscitation.

Authors:  M C Rogers
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

2.  Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons.

Authors:  L G Svensson; C M Von Ritter; H T Groeneveld; E S Rickards; S J Hunter; M F Robinson; R A Hinder
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

Review 3.  The physiology of cerebral blood flow during cardiopulmonary resuscitation.

Authors:  I D Berkowitz; M C Rogers
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

Review 4.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

5.  The effects of nicardipine given after 10-minutes complete global cerebral ischemia on neurologic recovery in dogs.

Authors:  N Iwatsuki; K Ono; M Takahashi; T Tajima
Journal:  J Anesth       Date:  1990-10       Impact factor: 2.078

6.  Variation in serum ionized calcium on cardiopulmonary resuscitation.

Authors:  S Gando; I Tedo; H Tujinaga; M Kubota
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

7.  Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.

Authors:  B Grøgaard; B Gerdin; K E Arfors
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.